Get the Stockscreener App
1.22
0.82%
0.00
Co Diagnostics Inc stock is traded at $1.22, with a volume of 17,779.
It is up +0.82% in the last 24 hours and down -3.91% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$1.22
Open:
$1.22
24h Volume:
17,779
Relative Volume:
0.07
Market Cap:
$38.61M
Revenue:
$4.66M
Net Income/Loss:
$-42.56M
P/E Ratio:
-0.9839
EPS:
-1.24
Net Cash Flow:
$-22.51M
1W Performance:
+1.65%
1M Performance:
-3.91%
6M Performance:
+1.65%
1Y Performance:
-7.52%
1-Day Range:
$1.20
$1.23
1-Week Range:
$1.17
$1.24
52-Week Range:
$1.00
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024 - WV News
Analyzing Insulet (NASDAQ:PODD) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Relea - GuruFocus.com
Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - BioSpace
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024 - PR Newswire
Some of the Key Players in the Emerging Infectious Disease Diagnostics Market : - InsightAce Analytic
Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles - Yahoo Finance
The APAC Coronavirus Test Kits Market is projected to grow by USD 2.87 Billion (2024-2028), driven by increased availability of test kits and AI-powered market evolutionTechnavio - Lelezard
In-vitro Diagnostics Kit Market is Expected to See a Growth of 4.40% CAGR from 2024 to 2034 | Future Market Insights, Inc. – Market Research Blog - Market Research Blog
Coronavirus Test Kits Market in North America to Shrink by USD 1.41 Billion (2024-2028) as Integration with Routine Healthcare Evolves, AI-Powered Report by Technavio - The Malaysian Reserve
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - StockTitan
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 30.9% in September - Defense World
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - StockTitan
Co-Diagnostics (CODX) Price Target Increased by 50.00% to 3.06 - MSN
Co-Diagnostics Inc Inc. (CODX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Co-Diagnostics' Mpox test effective against new clade - Investing.com
Co-Diagnostics completes updated clade Ib analysis of 2-Gene Mpox RUO test - TipRanks
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test - PR Newswire
Multiplex Assay Market to Soar USD 6.75 Bn by 2034: Projections Show 4x Growth Driven by Innovations in Diagnostics and Drug Discovery - BioSpace
How does Co-Diagnostics Inc (CODX) change from a tortoise to a hare? - SETE News
Balance Sheet Insights: Co-Diagnostics Inc (CODX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Co-Diagnostics Inc (CODX) shows promising results - US Post News
Co-Diagnostics sees shareholder backing in annual meeting votes By Investing.com - Investing.com South Africa
Co-Diagnostics sees shareholder backing in annual meeting votes - Investing.com
Closing Bell Recap: Co-Diagnostics Inc (CODX) Ends at 1.58, Reflecting a -9.71 Downturn - The Dwinnex
Co-Diagnostics Inc (CODX) presents a great opportunity, but the stock is slightly undervalued - US Post News
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? - Yahoo Finance
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13 - BioSpace
2024 Report | United States Autoimmune Disease Diagnostics - GlobeNewswire
Financial Metrics Unveiled: Co-Diagnostics Inc (CODX)’s Key Ratios in the Spotlight - The Dwinnex
Views of Wall Street’s Leading Experts on Co-Diagnostics Inc - SETE News
Co-Diagnostics (NASDAQ:CODX) adds US$8.6m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Co-Diagnostics Inc Inc. (CODX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Genolution triples mpox diagnostic kit production capacity with completion of new Songdo facility - KBR
Will Co-Diagnostics Inc (CODX) meet earnings estimates this quarter? - US Post News
Co-Diagnostics stock hits 52-week high at $1.73 amid market rally - Investing.com Canada
Short Interest in Co-Diagnostics, Inc. (NASDAQ:CODX) Drops By 12.3% - Defense World
Co-Diagnostics (FRA:C97) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
Co-Diagnostics stock hits 52-week high at $1.73 amid market rally By Investing.com - Investing.com South Africa
CODXCo-Diagnostics, Inc. Latest Stock News & Market Updates - StockTitan
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - PR Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) Expected to Post Q3 2024 Earnings of ($0.33) Per Share - Defense World
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast - Longview News-Journal
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast - Longview News-Journal
Co-Diagnostics (NASDAQ:CODX) Price Target Cut to $1.50 by Analysts at HC Wainwright - Defense World
Earnings call: Co-Diagnostics Q2 earnings reflect growth and optimism By Investing.com - Investing.com Australia
Earnings call: Co-Diagnostics Q2 earnings reflect growth and optimism - Investing.com
Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2024 Earnings Call Transcript - Insider Monkey
Co-Diagnostics Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):